DC
AMAG

Deere & Company’s AMAG Pharmaceuticals AMAG Stock Holding History

Deere & Company’s Portfolio AMAG Stock Details AMAG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-9,611
Closed -$233K – 1093
2013
Q4 		$233K Sell
9,611
-13,708
-59% -$322K 0.01% 848
2013
Q3 		$501K Hold
23,319
– – 0.03% 651
2013
Q2 		$519K Buy
+23,319
New +$514K 0.03% 637

Other funds holding AMAG

Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
VAM
Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Deere & Company's AMAG Position: Q1 2014 in Review

Deere & Company sold out of AMAG Pharmaceuticals (AMAG) in Q1 2014, closing a stake of 9,611 shares — an estimated $233K sold.

Deere & Company first reported a position in AMAG in Q2 2013 and held it in 3 quarters. The position peaked at $519K in Q2 2013. 102 funds tracked by Wall St. Rank hold AMAG as of Q1 2014.

  • Deere & Company reported no remaining AMAG Pharmaceuticals position as of Q1 2014 after selling out during the quarter.
  • Deere & Company sold 9,611 AMAG Pharmaceuticals shares in Q1 2014, an estimated $233K.
  • Deere & Company first reported a position in AMAG Pharmaceuticals in Q2 2013 and held it in 3 quarters.
  • Deere & Company's AMAG Pharmaceuticals position peaked at $519K in Q2 2013.
  • 102 funds tracked by Wall St. Rank held AMAG Pharmaceuticals as of Q1 2014.

Based on Deere & Company's 13F filing for Q1 2014, filed 8 May 2014.